Meluzio Michael Vincent Insider Trades & Stock Holdings
Meluzio Michael Vincent, VP, Prin. Accounting Officer at Cue Biopharma, Inc. has 1 Form 4 trade on file since Oct 12, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($32.09K), net -$32.09K. Latest filing: disposed of 1.14K shares of $CUE on Oct 12, 2026 at $28.05.
- Trades on file
- 1
- Open-market bought
- $0
- Open-market sold
- $32.09K
- Net open-market
- -$32.09K
- Latest filing
- Oct 12, 2026
All insider trades by Meluzio Michael Vincent
| Date | Ticker | Type | Shares | Price | Value | Owned after | ΔOwn | 1W | 1M | 6M | Role | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $CUE | Sell (Open-market sale) | 1.14K | $28.05 | $32.09K | VP, Prin. Accounting Officer | Read |
"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.
Stocks Meluzio Michael Vincent traded
Frequently asked questions
Has Meluzio Michael Vincent been buying or selling stock?
Meluzio Michael Vincent has 0 open-market purchases and 1 open-market sale on file, net -$32.09K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.
What was Meluzio Michael Vincent's latest insider trade?
disposed of 1.14K shares of $CUE on Oct 12, 2026 at $28.05.
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.